Our Mission Contact Us What's New Programs and Services NEHA Staff NEHA Board of Directors Employment
Hemophilia Von Willebrand Disease Rare Factor Deficiencies Women's Disorders
Statement of Purpose State Issues National Issues
Treatments Centers Other Resources Sponsorship Scholarships
Become a Member Make a Donation Corporate Opportunities Volunteering Fundraising
Hemophilia

Hemophilia is a genetic disorder which creates problems in the body’s blood clotting system. It is caused by a deficiency of factor VIII or factor IX.  As a result, stable clots do not form and prolonged bleeding occurs. Hemophilia can be mild, moderate or severe, depending on factor levels in the blood. Contrary to popular myth, persons with bleeding disorders will not bleed to death from a cut or minor injury. They suffer mostly from internal bleeding into joints and muscles.

Hemophilia affects males most severely, but we now know females can have hemophilia too. Inhibitors in hemophilia present complicated treatment challenges. Hemophilia medicines, called factor concentrates, are among the most expensive medicines on the market. There are an estimated 1,000 persons with hemophilia in New England and 20,000 in the United States. For more information about Hemophilia and Bleeding Disorders, click here.

Inhibitors -- For more information, click here.